Chemed Corp. (CHE)

NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-11-04

$533.77-2.71%

Close 2026-11-05 · 1-day change

QuarterlyIQ Insights · CHE

News & Events

Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.

Type

Direction

33 matches

2026-10-27Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On October 27, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2026-07-28Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On July 28, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2026-04-23Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On April 23, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2026-04-13Item 1.01
CHE — credit agreement
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”). JPMorgan Chase Bank, N.A., acted as the Administrative Agent, Joint Lead Arranger and Joint Bookrunner. Bank of America, N.A., acted as Joint Lead Arranger, Joint Bookrunner and Syndication Agent. PNC Bank, N.A. and U.S. Bank, N.A. were Co-Documentation Agents. Terms of the Credit Facilities consist of a five-year…
Capital allocationcredit agreementneutral
2026-04-13Item 2.03
CHE — capital allocation — CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALAN…
CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT The information set forth above under
Capital allocationnegative
2026-02-25Item 2.02
CHE — earnings miss
Results of Operations and Financial Condition On February 25, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended December 31, 2025. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings missnegative
2025-10-28Item 2.02
CHE — earnings miss
Results of Operations and Financial Condition On October 28, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings missnegative
2025-07-29Item 2.02
CHE — earnings miss
Results of Operations and Financial Condition On July 29, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings missnegative
2025-07-29Item 5.02
CHE — CEO transition
CEO — Nicholas M. Westfall: The CEO of a subsidiary (Vitas) is resigning to pursue other interests, which constitutes a genuine executive departure, though the neutral direction reflects the stated reason and his continued role at the parent company.
Executive changedepartureneutral
2025-04-23Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On April 23, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2025. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2025-02-26Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On February 26, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended December 31, 2024. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2024-10-29Item 2.02
CHE — earnings miss
Results of Operations and Financial Condition On October 29, 2024, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2024. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings missnegative
2024-07-24Item 2.02
CHE — earnings miss
Results of Operations and Financial Condition On July 24, 2024, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2024. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings missnegative
2024-04-24Item 2.02
CHE — earnings miss
Results of Operations and Financial Condition On April 24, 2024, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2024. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings missnegative
2024-04-17Item 2.01
CHE — acquisition announced
Completion of Acquisition or Disposition of Assets VITAS Acquisition On April 17, 2024, Chemed issued a press release announcing that VITAS Healthcare Corporation (“VITAS”), a wholly-owned indirect subsidiary of Chemed, completed its acquisition of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc., d/b/a Covenant Care, a Florida not for profit corporation (“Covenant”), for $85 million. Covenant operated hospice services in t…
M&A activityacquisition announcedpositive
2024-02-27Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On February 27, 2024, Chemed Corporation issued a press release announcing its financial results for the quarter ended December 31, 2023. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2023-11-03Item 5.02
CHE — CFO transition
CFO — David P. Williams: The CFO is retiring with a specific effective date, which is an orderly succession rather than a sudden loss or shock.
Executive changeretirement successionneutral
2023-10-25Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On October 25, 2023, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2023. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2023-07-26Item 2.02
CHE — earnings miss
Results of Operations and Financial Condition On July 26, 2023, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2023. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings missnegative
2023-04-26Item 2.02
CHE — earnings in line
Results of Operations and Financial Condition On April 26, 2023, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2023. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings inlineneutral
2023-02-23Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On February 23, 2023 Chemed Corporation issued a press release announcing its financial results for the quarter ended December 31, 2022. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2022-11-07Item 5.02
CHE — director transition
Director — John M. Mount, Jr.: The filing discloses the appointment of a new independent director to the Board and Audit Committee, which is a routine governance event rather than an executive departure.
Executive changeboard electionneutral
2022-10-31Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On October 31, 2022 Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2022. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive
2022-08-05Item 5.02
CHE — director transition
Director — Donald E. Saunders: A director retired and was immediately replaced by a new appointment, representing an orderly succession rather than a sudden loss of senior management.
Executive changeretirement successionneutral
2022-07-27Item 2.02
CHE — earnings beat
Results of Operations and Financial Condition On July 27, 2022 Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2022. A copy of the release is furnished herewith as Exhibit 99.
Earnings preannouncementearnings beatpositive

Coming next

General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.